Suresh Magalam

Suresh Magalam

Active Director Director DIN 08339494
DIN 08339494 First appointment Jan 2019 Primary industry E-Commerce
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value •••• Premium profile

About Suresh Magalam

Data last updated:

Suresh Magalam is a Director at Hita Healthcare Private Limited (since 2019). The company operates in E-Commerce. Hita Healthcare Private Limited reported revenue of ₹1.06 Cr (FY 2025).

DIN 08339494
Primary Designation Director
Industry E-Commerce
First Appointment 22 Jan 2019
Oldest Company Age 7 yrs
Largest company Hita Healthcare Private Limited · ₹1.06 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hita Healthcare Private Limited U15400KA2019PTC120662
Director22 Jan 20192019₹1.06 Cr (FY 2025)Active

Board colleagues of Suresh Magalam

Directorship timeline

Open interactive timeline →
Hita Healthcare Private Limited
Premium access

Shareholding and investment profile for Suresh Magalam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Magalam

Suresh Magalam currently holds 1 directorship: Hita Healthcare Private Limited (Director, since 22 Jan 2019, revenue ₹1.06 Cr (FY 2025)).

Suresh Magalam was first appointed on 22 Jan 2019 as Director at Hita Healthcare Private Limited.

The current boards of Suresh Magalam's companies include Raghunandan Thekalli Vasudevamurthy (Hita Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available